These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29082908)

  • 1. Progestogen-only injectable contraceptive: Acceptor prevalence and client experience at Sagamu, Nigeria.
    Akadri AA; Odelola OI
    Niger Postgrad Med J; 2017; 24(3):178-181. PubMed ID: 29082908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with injectable progestogen- only contraceptives at University of Ilorin teaching hospital: a five year review.
    Balogun OR; Raji HO
    Niger Postgrad Med J; 2009 Dec; 16(4):260-3. PubMed ID: 20037621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A five year review of the complications of progestogen only injectable contraceptive at the University of Port-Harcourt Teaching Hospital.
    Ojule JD; Oriji VK; Okongwu C
    Niger J Med; 2010; 19(1):87-95. PubMed ID: 20232762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestogen-only injectable contraceptive: experience of women in Osogbo, southwestern Nigeria.
    Adeyemi AS; Adekanle DA
    Ann Afr Med; 2012; 11(1):27-31. PubMed ID: 22199044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria.
    Hu E; Ikeako LC; Obiora-Okafor NC
    Niger J Med; 2012; 21(3):266-71. PubMed ID: 23304918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depot medroxyprogesterone injectable contraception at the University of Uyo Teaching Hospital, Uyo.
    Abasiattai AM; Udoma EJ; Ukeme E
    Ann Afr Med; 2010; 9(2):81-5. PubMed ID: 20587929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year experience with depot medroxy progesterone acetate injectable contraception.
    Ezugwu FO; Anya SE
    Niger J Med; 2005; 14(4):408-10. PubMed ID: 16353702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women's acceptance of an injectable progestin-only contraceptive in a free-choice environment in Turkey.
    Say L; Ortayli N; Nalbant H
    Eur J Contracept Reprod Health Care; 2000 Mar; 5(1):68-70. PubMed ID: 10836665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Femiject, a once-a-month combined injectable contraceptive: experience from Pakistan.
    Izhar R; Husain S; Tahir MA; Husain S
    Eur J Contracept Reprod Health Care; 2020 Oct; 25(5):359-364. PubMed ID: 32757796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable contraceptives: underused and undervalued?
    Parker C
    Prof Care Mother Child; 1997; 7(4):95-7. PubMed ID: 9348967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception.
    Draper BH; Morroni C; Hoffman M; Smit J; Beksinska M; Hapgood J; Van der Merwe L
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD005214. PubMed ID: 16856087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestin-only contraception: injectables and implants.
    Jacobstein R; Polis CB
    Best Pract Res Clin Obstet Gynaecol; 2014 Aug; 28(6):795-806. PubMed ID: 24996766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of job aids on knowledge retention among Patent and Proprietary Medicine Vendors trained to administer injectable contraceptives: longitudinal results from implementation science in Nigeria.
    Chace Dwyer S; Jain A; Ishaku SM; Okunade FT; Uzomba C; Adebayo A; Tobey E
    BMC Public Health; 2019 Oct; 19(1):1362. PubMed ID: 31651273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa.
    Smit J; McFadyen L; Zuma K; Preston-Whyte E
    Soc Sci Med; 2002 Nov; 55(9):1511-22. PubMed ID: 12297238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuation of injectable contraceptives in Thailand.
    Narkavonnakit T; Bennett T; Balakrishnan TR
    Stud Fam Plann; 1982 Apr; 13(4):99-105. PubMed ID: 6216633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
    Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Discontinuation of Subdermal Levonorgestrel Implants (Jadelle) at the Lagos University Teaching Hospital, Lagos, Nigeria: An Analytic Cohort Study.
    Ohazurike E; Olamijulo JA; Ibisomi L; Olorunfemi G; Oluwole AA
    Afr J Reprod Health; 2020 Jun; 24(2):48-63. PubMed ID: 34077091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family planning practice in a tertiary health institution in Southern Nigeria.
    Ojule JD; Macpepple DA
    West Afr J Med; 2011; 30(3):178-81. PubMed ID: 22120482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting steroids provide new options.
    Netw Res Triangle Park N C; 1988; 9(3):1-3, 7. PubMed ID: 12315656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.